Buer, J.
1473  Ergebnisse:
Personensuche X
?
1

P877 A comparison of vedolizumab and ustekinumab treatment ..:

Helm Wiken, T E ; Høivik, M L ; Buer, L...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1619-i1619 , 2024
 
?
3

Infection prevention and control between legal requirements..:

Mardiko, A.A. ; Buer, J. ; Köster, A.M....
Journal of Hospital Infection.  137 (2023)  - p. 35-43 , 2023
 
?
5

P376 Switching from intravenous to subcutaneous vedolizumab..:

Wiken, T ; Høivik, M L ; Buer, L...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i378-i379 , 2022
 
?
8

P516 The use of first-line biologics in patients with ulcer..:

Anisdahl, K ; Lirhus, S ; Medhus, A...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S371-S371 , 2019
 
?
11

P710 The use of first-line biologics in patients with Crohn..:

Anisdahl, K ; Lirhus, S ; Medhus, A...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S475-S476 , 2019
 
?
12

Prevalence and characterization of azole-resistant Aspergil..:

Seufert, R ; Sedlacek, L ; Kahl, B...
Journal of Antimicrobial Chemotherapy.  73 (2018)  8 - p. 2047-2053 , 2018
 
?
15

P514 Combination treatment with vedolizumab and anti-TNF-α ..:

Buer, L. ; Høivik, M.L. ; Medhus, A.W..
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S341-S342 , 2017
 
1-15